Entering text into the input field will update the search result below

ZS Pharma eyes $86M+ IPO

May 15, 2014 10:01 AM ETRenaissance IPO ETF (IPO)IPOBy: Yigal Grayeff, SA News Editor
  • ZS Pharma has filed to raise $86.25M in an IPO on Nasdaq, where it intends to trade under the symbol ZSPH.
  • The biotech develops ZS-9, a treatment for hyperkalemia, which is a life-threatening condition in which high blood-potassium levels increase the risk of muscle dysfunction.
  • ZS-9 met its primary and secondary efficacy endpoints in one Phase III trial and is now being tested in another late-stage study. ZS Pharma also plans to start a long-term safety study this quarter.
  • ZS Pharma initially filed confidentially for its listing on April 4. (S-9)
  • ETF: IPO

Recommended For You

More Trending News

About IPO ETF

SymbolLast Price% Chg
Expense Ratio
Div Frequency
Div Rate (TTM)
Yield (TTM)
Assets (AUM)
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IPO--
Renaissance IPO ETF